Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Genetic Reduction or Negative Modulation of mGlu7 Does Not Impact Anxiety and Fear Learning Phenotypes in a Mouse Model of MECP2 Duplication Syndrome.
ACS Chem Neurosci. 2018 Sep 19;9(9):2210-2217. doi: 10.1021/acschemneuro.7b00414. Epub 2017 Dec 14.
ACS Chem Neurosci. 2018.
PMID: 29227625
Free PMC article.
Profiling beneficial and potential adverse effects of MeCP2 overexpression in a hypomorphic Rett syndrome mouse model.
Vermudez SAD, Gogliotti RG, Arthur B, Buch A, Morales C, Moxley Y, Rajpal H, Conn PJ, Niswender CM.
Vermudez SAD, et al.
Genes Brain Behav. 2022 Jan;21(1):e12752. doi: 10.1111/gbb.12752. Epub 2021 May 28.
Genes Brain Behav. 2022.
PMID: 34002468
Free PMC article.
Item in Clipboard
Frontal cortex genetic ablation of metabotropic glutamate receptor subtype 3 (mGlu3) impairs postsynaptic plasticity and modulates affective behaviors.
Joffe ME, Santiago CI, Vermudez SAD, Fisher NM, Dogra S, Niswender CM, Jeffrey Conn P.
Joffe ME, et al. Among authors: vermudez sad.
Neuropsychopharmacology. 2021 Nov;46(12):2148-2157. doi: 10.1038/s41386-021-01041-2. Epub 2021 May 25.
Neuropsychopharmacology. 2021.
PMID: 34035469
Free PMC article.
Item in Clipboard
Exploration of group II metabotropic glutamate receptor modulation in mouse models of Rett syndrome and MECP2 Duplication syndrome.
Vermudez SAD, Buch A, Weiss K, Gogliotti RG, Niswender CM.
Vermudez SAD, et al.
Neuropharmacology. 2022 May 15;209:109022. doi: 10.1016/j.neuropharm.2022.109022. Epub 2022 Mar 3.
Neuropharmacology. 2022.
PMID: 35248529
Free PMC article.
Item in Clipboard
Clinical and Preclinical Evidence for M1 Muscarinic Acetylcholine Receptor Potentiation as a Therapeutic Approach for Rett Syndrome.
Smith M, Arthur B, Cikowski J, Holt C, Gonzalez S, Fisher NM, Vermudez SAD, Lindsley CW, Niswender CM, Gogliotti RG.
Smith M, et al. Among authors: vermudez sad.
Neurotherapeutics. 2022 Jul;19(4):1340-1352. doi: 10.1007/s13311-022-01254-3. Epub 2022 Jun 7.
Neurotherapeutics. 2022.
PMID: 35670902
Free PMC article.
Item in Clipboard
Seizure reduction in TSC2-mutant mouse model by an mTOR catalytic inhibitor.
Dhamne SC, Modi ME, Gray A, Bonazzi S, Craig L, Bainbridge E, Lalani L, Super CE, Schaeffer S, Capre K, Lubicka D, Liang G, Burdette D, McTighe SM, Gurnani S, Vermudez SAD, Curtis D, Wilson CJ, Hameed MQ, D'Amore A, Rotenberg A, Sahin M.
Dhamne SC, et al. Among authors: vermudez sad.
Ann Clin Transl Neurol. 2023 Oct;10(10):1790-1801. doi: 10.1002/acn3.51868. Epub 2023 Aug 6.
Ann Clin Transl Neurol. 2023.
PMID: 37545094
Free PMC article.
Item in Clipboard
Depressed glutamate transporter 1 expression in a mouse model of Dravet syndrome.
Hameed MQ, Hui B, Lin R, MacMullin PC, Pascual-Leone A, Vermudez SAD, Rotenberg A.
Hameed MQ, et al. Among authors: vermudez sad.
Ann Clin Transl Neurol. 2023 Sep;10(9):1695-1699. doi: 10.1002/acn3.51851. Epub 2023 Jul 14.
Ann Clin Transl Neurol. 2023.
PMID: 37452008
Free PMC article.
Item in Clipboard
Cite
Cite